Krishna Institute of Medical Sciences (KIMS) Share Price Falls 2.48% as KIMS Trades at Rs 751

KIMS Share Price is in focus after Krishna Institute of Medical Sciences traded at Rs 751, down 2.48% from the previous close of Rs 770.1. The stock’s market capitalisation stood at Rs 32,180.9 crore, keeping it in the Large Cap category and placing KIMS Share Price among the closely watched names in healthcare. The price move is confirmed in Univest data; a company-specific reason has not been established. For KIMS Share Price Today, the key reading is straightforward: the decline was visible in intraday price action, while valuation and sector positioning remain central to KIMS Stock News and KIMS Share Price News today. Investors tracking KIMS Share Price can read the move as a price event first, then place it against fundamentals, sector benchmarks and peers.

Krishna Institute of Medical Sciences (KIMS) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 751
Previous Close	Rs 770.1
Today's Move	-Rs 19.10 (-2.48%)
Open	Rs 763.75
High	Rs 777.7
Low	Rs 738.65
Market Capitalisation	Rs 32,180.9 crore
Market Cap Category	Large Cap

KIMS Share Price Today shows an intraday decline that started from an opening level of Rs 763.75, moved to a high of Rs 777.7 and touched a low of Rs 738.65 before trading at Rs 751. The day change was Rs -19.1, or -2.48%, versus the previous close of Rs 770.1. That places KIMS Share Price below the opening level and nearer the lower end of the day’s range. With a market cap of Rs 32,180.9 crore, KIMS Share Price remains a Large Cap name, which often keeps daily moves under close watch. In KIMS Share Price News, the important point is the confirmed fall itself, not any unverified explanation. For investors following KIMS Stock Falling Today, the price action confirms weakness in the stock without changing the need to review valuation and fundamentals next.

Krishna Institute of Medical Sciences (KIMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 32,180.9 crore
P/E Ratio	158.32x
P/B Ratio	8.55x
ROE	11.04%
ROCE	11.51%
EPS	Rs 4.86
Book Value Per Share	Rs 90.09
Dividend Yield	0%

KIMS Fundamental Analysis starts with the market capitalisation of Rs 32,180.9 crore and an enterprise-value-led equity profile that investors usually read alongside profitability ratios. KIMS Share Price corresponds to a P/E ratio of 158.32 and a P/B ratio of 8.55, both elevated versus many healthcare names in the peer set. ROE stood at 11.04%, while ROCE was 11.51%, showing returns that are positive but below several stronger peer readings. EPS was Rs 4.86, which helps explain why KIMS Share Price is valued at a rich earnings multiple. Book value per share stood at Rs 90.09, giving a useful accounting anchor to KIMS Share Price. Dividend yield was 0%, so income support is not part of the current valuation picture. In KIMS Financial Results and KIMS Stock Analysis discussions, these numbers matter because they show a stock priced richly relative to its earnings base, even before sector benchmarking. Univest data points to valuation as the main context for KIMS Share Price rather than any single operating trigger.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	158.32x
Benchmark Median P/E	46.9x
Benchmark Average P/E	100.02x
Benchmark P/E Range	6.8x to 1,572.9x
Company P/B Ratio	8.55x
Benchmark Median P/B	3.88x
Benchmark Average P/B	4.71x
Company ROE	11.04%
Benchmark Median ROE	13.01%
Benchmark Average ROE	12.87%
Company ROCE	11.51%
Benchmark Median ROCE	15.84%
Benchmark Average ROCE	2.83%
Company Market Capitalisation	Rs 32,180.9 crore
Benchmark Median Market Cap	Rs 578.29 crore
Benchmark Average Market Cap	Rs 11,352.34 crore

Sector analysis places KIMS Share Price inside Healthcare and the Hospital & Healthcare Services industry, where the benchmark scope covers the same industry and 65 companies. In that set, KIMS Share Price has a P/E of 158.32 versus a median of 46.9 and an average of 100.02, which keeps the stock above both reference points. The benchmark range runs from 6.8 to 1,572.9, so KIMS remains inside a broad but clearly expensive-looking zone on earnings multiples. On P/B, KIMS Share Price at 8.55 is above the industry median of 3.88 and above the average of 4.71. ROE at 11.04% is slightly below the sector median of 13.01%, while ROCE at 11.51% is below the median of 15.84%. The benchmark includes 65 companies for market cap, where the median is Rs 578.29 crore and the average is Rs 11,352.34 crore; KIMS Share Price sits well above both. In healthcare stock analysis, that mix of rich valuation and mid-single-digit-to-low-double-digit return metrics is the central comparison point.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,27,421.96	59.88	12.92	23.54	21.73
Max Healthcare Institute	MAXHEALTH	97,418.62	65.73	8.76	14.53	14.97
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	94,970.23	110.4	5.4	12.95	13.93
Aster DM Healthcare	ASTERDM	65,183.66	201.12	15.15	13.07	16.22
Fortis Healthcare	FORTIS	62,782.32	59.01	6.08	11.32	14.07

Peer comparison gives KIMS Share Price more context. Against Apollo Hospitals Enterprise, Max Healthcare Institute, Manipal Health Enterpri L, Aster DM Healthcare, Fortis Healthcare, Global Health, Narayana Hrudayalaya and Dr. Lal Pathlabs, KIMS Share Price sits in the Large Cap group but below Apollo and Max on market capitalisation. Its P/E of 158.32 is higher than Apollo at 59.88, Max at 65.73, Fortis at 59.01, Global Health at 68.43 and Narayana Hrudayalaya at 45.15. Only Aster at 201.12 is higher, while Manipal at 110.4 is also below KIMS. On ROE, KIMS Share Price at 11.04% trails Apollo, Max, Global Health, Narayana Hrudayalaya and Dr. Lal Pathlabs, and sits close to Fortis. On ROCE, KIMS is below Apollo, Max, Global Health, Narayana Hrudayalaya and Dr. Lal Pathlabs, while remaining above some lower-return peers. This peer set suggests that KIMS Share Price is not low-valued on valuation, even though its market cap is substantial within healthcare.

Why Investors Are Watching KIMS

• KIMS Share Price fell 2.48% and remains one of the most closely watched healthcare names in today’s market update.
• The current P/E of 158.32 keeps KIMS Share Price in a rich valuation zone versus the industry median and average.
• ROE at 11.04% and ROCE at 11.51% give investors a clear profitability and capital-return reference point.
• KIMS Share Price is a Large Cap stock with a market cap of Rs 32,180.9 crore, so daily moves remain meaningful.
• Peer comparison shows KIMS Share Price trading at a higher earnings multiple than several listed healthcare peers.

About KIMS

Krishna Institute of Medical Sciences operates in the Healthcare sector and the Hospital & Healthcare Services industry. The business is known for hospital-led healthcare delivery, which places KIMS Share Price within a service model focused on patient care, infrastructure and medical operations. Investors following KIMS Stock News usually track the company as part of the broader listed hospital universe. In this context, KIMS Share Price reflects a Large Cap healthcare business with a significant market presence. The company’s valuation and profitability ratios matter because hospital businesses are typically assessed on scale, returns and consistency. KIMS Share Price therefore sits at the intersection of business execution and market valuation, which is why fundamental analysis remains relevant after each price move.

Track KIMS Share Price on Univest

Use Krishna Institute of Medical Sciences (KIMS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Investors can track KIMS Share Price on Univest for live share price movement, valuation ratios, market capitalisation, 52-week levels and company insights. Univest also brings together KIMS Share Price Today, KIMS Stock News and KIMS Fundamental Analysis in one place, making it easier to review market cap, returns and peer context. For readers comparing healthcare names, Univest keeps KIMS Share Price alongside sector and industry benchmarks without turning the process into a guesswork exercise.

Frequently Asked Questions

Why did KIMS Share Price fall today?

Ans. KIMS Share Price fell 2.48% to Rs 751 from the previous close of Rs 770.1. The price move is confirmed in Univest data; a company-specific reason has not been established.

What is KIMS Share Price today?

Ans. KIMS Share Price traded at Rs 751 at the time of the update. The stock moved between Rs 738.65 and Rs 777.7 during the session, with an opening price of Rs 763.75.

What is the market capitalisation of KIMS?

Ans. KIMS Share Price is backed by a market capitalisation of Rs 32,180.9 crore. That places Krishna Institute of Medical Sciences in the Large Cap category and keeps it in the active healthcare coverage universe.

Is KIMS Share Price expensive on valuation?

Ans. KIMS Share Price trades at a P/E of 158.32 and a P/B of 8.55. Both are above the industry median and average, so the stock looks rich on valuation relative to its healthcare peers.

How do KIMS margins and returns compare with peers?

Ans. KIMS Share Price is associated with ROE of 11.04% and ROCE of 11.51%. Those readings are below several listed healthcare peers, so returns remain an important reference point in KIMS Stock Analysis.

What does EPS mean for KIMS Share Price?

Ans. KIMS EPS is Rs 4.86, which shows earnings attributable to each share. For KIMS Share Price, that EPS helps explain why the market is assigning a high earnings multiple to the stock.

What does book value indicate for KIMS?

Ans. KIMS book value per share is Rs 90.09. For KIMS Share Price, this is the accounting net worth behind each share and gives investors a useful comparison point with the current trading level.

How does KIMS compare with healthcare peers?

Ans. KIMS Share Price has a higher P/E than Apollo Hospitals, Max Healthcare and Fortis, while also trading above the sector median. That makes peer comparison important when reviewing KIMS Stock News and valuation.